GlassScriptPhysician profile
William C Cosman
NPI 1326099789
$6,636.58
in general payments reported to CMS, 2019-2025
18 companies · $602 in 2025
The $602 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $208 · 2021: $20.52 · 2022: $349 · 2023: $1,337 · 2024: $3,786 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,989 · Food and Beverage: $2,709 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,989.45 |
| Food and Beverage | $2,709.12 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $4,138.61 | 2023-2024 | |
| Alcon Vision LLC | $1,476.31 | 2019-2025 | Clareon, Lensx, Hydrus Microstent |
| Abbvie INC. | $171.00 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $148.79 | 2025 | Xdemvy |
| Rxsight INC | $120.55 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Novartis Pharmaceuticals Corporation | $109.72 | 2020-2023 | |
| Sight Sciences, INC. | $83.73 | 2020-2025 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $81.48 | 2022-2024 | Xiidra, Miebo |
| Glaukos Corporation | $81.48 | 2025 | Idosetr |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Oyster Point Pharma, INC. | $41.86 | 2022-2024 | Tyrvaya |
| Amgen INC. | $21.98 | 2025 | Tepezza |
| Leadiant Biosciences, INC. | $21.27 | 2022 | |
| Ivantis, INC | $17.45 | 2020 | |
| Horizon Therapeutics Plc | $16.29 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $15.63 | 2025 | Vevye |
| Shire North American Group INC | $13.12 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $12.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cosman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.